Pharminent

Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca

[Business Wire] – Pfizer Inc. today announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca’s late-stage small molecule anti-infective business, primarily outside the United States. http://finance.yahoo.com/news/pfizer-completes-acquisition-small-molecule-070500358.html

Filed under: Company